Editor-in-Chief İlkay Küçükgüzel Associate Editor Esra Tatar Online ISSN 2630-6344 Publisher Marmara University Frequency Bimonthly (Six issues / year) Abbreviation J.Res.Pharm. Former Name Marmara Pharmaceutical Journal
Journal of Research in Pharmacy 2019 , Vol 23 , Issue 6
The role of the clinical pharmacist in patient education and monitoring of patients under warfarin treatment
Fikret Vehbi İZZETTİN1,Sevda ÇELİK2,Rezzan Deniz ACAR3,Songül TEZCAN2,Nilay AKSOY4,Muhammed Yunus BEKTAY1,Mesut SANCAR2
1Department of Clinical Pharmacy, Faculty of Pharmacy, Bezmialem Vakif University, Istanbul, Turkey
2Department of Clinical Pharmacy, Faculty of Pharmacy, Marmara University, Istanbul, Turkey
3Kartal Koşuyolu Training Research Hospital, Istanbul, Turkey
4Department of Clinical Pharmacy, Faculty of Pharmacy, Altinbas University, Istanbul, Turkey
DOI : 10.35333/jrp.2019.81 This study was carried out on patients who were under anticoagulation treatment with warfarin, at the outpatient cardiology clinic. The aim was to determine the effectiveness of pharmacist consultation, education, and intervention on each patient’s therapeutic results. A cross-sectional randomized trial has been done. Twenty-five patients were included in the study. The Oral Anticoagulation Knowledge (OAK) Test, Short Form-36 (SF-36) and Duke Anticoagulation Satisfaction Scale (DASS) were applied. Patients resumed their routine anticoagulation treatment and INR and complications were recorded during the study. Additionally, patients received patient education, consultation on lifestyle and anticoagulant usage issues from a pharmacist. The same tests were applied again to the patients on the 90th day of the study and the results were compared with the initial test. Maintenance of INR within the target range and complication rates were compared before and after the intervention. Pre-test and post-test results of the patients revealed statistically significant improvements on the physical and mental score components of the SF-36 (p = 0.001; p = 0.001), OAK test scores (p ≤ 0.001) and the (negative) “limitations” and “burdens” and “positive effects” components of the DASS (p = 0.005; p < 0.001; p = 0.001). The successful maintenance of INR within target range was significantly higher (p = 0.027). The positive effects of pharmacist consultation and education on therapeutic results were demonstrated. Keywords : Warfarin; anticoagulation; monitoring; clinical pharmacist
Marmara University